GoodRx Holdings, Inc.

GDRX Healthcare Health Information Services

GoodRx Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $796.9 million, up 0.57% from fiscal 2024.

Revenue
−1.31%
EPS
−25.0%
Free cash flow
+112.5%
Total debt
−0.69%

Quarter to June 2026, against a year earlier

3.49 0.00 0.00%
Market cap
$1.2B
P/E
65.7×
Fwd P/E
46.0×
Dividend yield
—
F-score
6/9
Altman Z
0.44
Beneish M
−2.40
Dividend safety
n/a

GoodRx Holdings, Inc. (GDRX) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, GoodRx Holdings, Inc. (GDRX) trades at a P/E ratio of 65.7×. Over the past ten years it has ranged from 0.0× (December 2024) to 843× (October 2020); the current reading is higher than 82% of that period. That is above the Health Information Services industry median of 42.0× and above the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 30.0× (69.37%)
FY2024 98.1× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 139× 0.00%
FY2018 139× 0.00%
FY2017 139× 0.00%
FY2016 139× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 53.7× 74.35%
Mar 2026 30.8× 2.57%
Dec 2025 30.0× (33.80%)
Sep 2025 45.4× (8.86%)
24 more quarters

Against its own ten years

Low 0.0× High 843×
Ten-year median 0.0×
Current reading's percentile 82

P/E ratio against peers

Company P/E ratio
CERT Certara, Inc. compare n/m
SDGR Schrodinger, Inc. compare n/m
TDOC Teladoc Health, Inc. compare n/m
OMCL Omnicell, Inc. compare 39.0×
HSTM HealthStream, Inc. compare 42.0×
GDRX GoodRx Holdings, Inc. 65.7×
PHR Phreesia, Inc. compare 74.4×
NRC National Research Corporation compare 87.6×
OMDA Omada Health, Inc. compare 267×
Health Information Services industry median 42.0×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on GDRX